Answers are grounded in this paper and cite their sources.
Our results suggested dysregulation of CB1R expression is closely related to the malignant biological behavior of gastric cancer cells. miRNA/CB1R-based therapy may represent a promising therapeutic strategy for the clinical treatment of GC patients.
No takes yet. Share an insight, caveat, or question.
Xian et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: